The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.
The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in ...
WISH-TV on MSN14h
High insulin prices spur lawsuit against 3 pharmacy benefit managers(AP) — The federal government is suing some big pharmacy benefit managers, or PBMs ... engaged in anticompetitive practices ...
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...
In January, a new Idaho law will take effect requiring reform of business practices by pharmacy middlemen — in search of tamping down prescription drug costs. The new law targets pharmacy benefit ...
The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...
Ethnic minorities in Bangladesh’s southern hilly region are living in fear after clashes in which four people were killed and dozens wounded, police and witnesses said on Saturday.
© 2024 BBC. The BBC is not responsible for the content of external sites. Read about our approach to external linking.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback